|
시장보고서
상품코드
2058207
헤파린나트륨 시장 : 제품 유형별, 원료별, 투여 경로별, 용도별, 최종사용자별, 유통 채널별, 지역별Heparin Sodium Market, By Product Type, By Source, By Route of Administration, By Application, By End User, By Distribution Channel, By Geography |
||||||
헤파린나트륨 시장은 2026년에 84억 2,000만 달러로 추정되며, 2033년까지 129억 6,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.4%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 84억 2,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 6.40% | 2033년 시장 규모 예측: | 129억 6,000만 달러 |
헤파린나트륨은 심부 정맥 혈전증, 폐색전증, 급성 관상동맥 증후군 등의 혈전색전증 예방 및 치료에 자주 처방되는 항응고제입니다. 이 약제는 혈액 응고를 억제하기 위해 심장 수술, 투석 치료, 체외 순환 및 기타 중환자 치료 상황에서 널리 사용되고 있습니다.
심혈관질환, 외과 수술 및 혈액투석 요법이 필요한 만성 신장질환의 유병률 증가가 전 세계 시장 수요를 뒷받침하는 주요 요인이 되고 있습니다. 또한, 고령화의 진행과 입원 환자 수의 증가 역시 의료기관에서의 항응고제 사용에 긍정적인 영향을 미치고 있습니다.
또한, 주사용 의약품 제조 기술의 발전과 프리믹스형 헤파린 제품의 등장으로 인해, 항응고제는 환자에게 더욱 편리하고 안전한 약물이 되었습니다. 각 제약사는 세계 시장에서 증가하는 항응고제 수요에 대응하기 위해 생산능력 확대와 공급망 강화에 힘쓰고 있습니다.
또한, 원료가 동물(주로 돼지)에서 유래한 것이기 때문에 제조 공정에서의 품질 기준과 추적 관리의 중요성도 커지고 있습니다. 또한, 개발도상국의 의료 인프라에 대한 투자 확대와 더불어 혈전증 예방 및 수술 전 항응고 치료에 대한 인식 제고를 통해, 향후 몇 년간 헤파린나트륨 산업의 성장이 예상됩니다.
시장 역학
전 세계 헤파린나트륨 시장은 항응고제가 필요한 심혈관질환, 정맥 혈전색전증, 폐색전증 및 만성 신장질환의 유병률 증가로 인해 상당한 성장을 이루어 왔습니다. 헤파린나트륨은 신속한 항응고 작용과 효능 덕분에 수술, 투석, 카테터 세척 및 체외순환 회로에서 여전히 필수적인 역할을 하고 있습니다. 병원이나 중환자실에 입원하는 환자 수가 증가함에 따라, 헤파린나트륨의 소비가 크게 늘어나고 있습니다. 또한, 개발도상국의 의료 인프라 개선은 향후 시장 성장을 뒷받침할 것입니다.
그러나 예측 기간 동안 시장 성장을 제약하는 몇 가지 요인이 존재합니다. 출혈이나 헤파린 유발성 혈소판 감소증과 같은 부작용의 위험이 있으므로 적절한 투여량 관리가 필수적이며, 이것이 외래 진료 분야에서의 헤파린나트륨 시장의 추가적인 발전을 저해하고 있습니다. 게다가, 헤파린나트륨 제조 과정에서 생산자가 동물 유래 원료, 특히 돼지 장 점막에 크게 의존하고 있다는 점은 원료 부족이나 가격 변동과 같은 공급망 리스크에 시장을 노출시키고 있습니다. 게다가 규제 강화와 의약품 제조 과정의 품질, 안전성, 투명성에 대한 감독 강화로 인해, 본 조사 대상 시장의 제조사들은 더욱 큰 압박을 받고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 헤파린나트륨 시장의 주요 기업 개요을 작성하였습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 전 세계 헤파린나트륨 시장에 관한 것으로, 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 헤파린나트륨 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 헤파린나트륨 시장 : 제품 유형별, 2021-2033년
제5장 세계의 헤파린나트륨 시장 : 원료별, 2021-2033년
제6장 세계의 헤파린나트륨 시장 : 투여 경로별, 2021-2033년
제7장 세계의 헤파린나트륨 시장 : 용도별, 2021-2033년
제8장 세계의 헤파린나트륨 시장 : 최종사용자별, 2021-2033년
제9장 세계의 헤파린나트륨 시장 : 유통 채널별, 2021-2033년
제10장 세계의 헤파린나트륨 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고문헌 및 조사 방법
KSM 26.06.19Heparin Sodium Market is estimated to be valued at USD 8.42 Bn in 2026 and is expected to reach USD 12.96 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.42 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.40% | 2033 Value Projection: | USD 12.96 Bn |
Heparin sodium is an anticoagulant drug that is frequently prescribed for preventing and treating thromboembolic conditions such as deep vein thrombosis, pulmonary embolism, and acute coronary syndrome. The medicine is largely applied in the course of heart surgeries, dialysis treatment, extracorporeal circulation, and other critical care applications in order to inhibit blood clotting.
Growing incidence of cardiovascular diseases, surgical procedures, and chronic kidney diseases necessitating hemodialysis therapy have become major drivers sustaining the market demand worldwide. Moreover, the increasing aged population and number of admissions into hospitals also positively influence the use of anticoagulant medications in medical institutions.
In addition, developments in the manufacturing of injectable pharmaceuticals and emergence of premixed heparin products make anticoagulants more convenient and safer for patients. Manufacturers of pharmaceuticals are making efforts to increase their production capacity and enhance supply chains to meet the rising demand for anticoagulant drugs in the global market.
There is also a growing importance attached to quality standards and traceability in the production process as the raw material is sourced from animals (mainly pigs). Furthermore, increased investment in health care infrastructure in developing countries, along with increased knowledge about thrombosis prevention and anticoagulation treatment before surgery, will likely create growth prospects for the heparin sodium industry in the coming years.
Market Dynamics
The global heparin sodium market has witnessed a significant growth due to the increasing prevalence of cardiovascular disorders, venous thromboembolism, pulmonary embolism, and chronic kidney disorders that demand anticoagulants. Heparin sodium has remained essential for use in surgeries, dialysis, catheter flush, and extracorporeal circuits because of its fast anticoagulant action and effectiveness. An increased number of patients admitted in hospitals and critical care units has made a considerable contribution in promoting the consumption of heparin sodium. Furthermore, improved healthcare infrastructure in developing nations will boost the future growth of the market.
Nonetheless, a number of issues may restrict the market growth over the forecast period. The threat of negative outcomes, such as hemorrhage and heparin-induced thrombocytopenia, makes the proper dosage control essential, preventing the further development of heparin sodium market in the outpatient segment. Additionally, the high dependence of the producers on animal sources for the production of heparin sodium, especially porcine intestinal mucosa, exposes the market to supply chain risks, which include the lack of materials and price changes. Moreover, growing regulation and increasing control over the quality, safety, and transparency of drug manufacturing have put additional pressure on manufacturers in the market under analysis.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global heparin sodium market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc., Sanofi, Baxter International Inc., B. Braun Melsungen AG, Aspen Pharmacare, LEO Pharma A/S, Dr. Reddy's Laboratories Ltd., Fresenius Kabi, Teva Pharmaceutical Industries Ltd., and Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global heparin sodium market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heparin sodium market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Unfractionated Heparin (UFH)
- Low Molecular Weight Heparin (LMWH)
- Source Insights (Revenue, USD Bn, 2021 - 2033)
- Porcine-derived
- Bovine-derived
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Intravenous
- Subcutaneous
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Venous Thromboembolism (VTE)
- Atrial Fibrillation & Coronary Artery Disease
- Kidney Dialysis
- Surgery & Critical Care
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Dialysis Centers
- Specialty Clinics
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Sanofi
- Baxter International Inc.
- Braun Melsungen AG
- Aspen Pharmacare
- LEO Pharma A/S
- Reddy's Laboratories Ltd.
- Fresenius Kabi
- Teva Pharmaceutical Industries Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Heparin Sodium Market, By Product Type
- Global Heparin Sodium Market, By Source
- Global Heparin Sodium Market, By Route of Administration
- Global Heparin Sodium Market, By Application
- Global Heparin Sodium Market, By End User
- Global Heparin Sodium Market, By Distribution Channel
- Global Heparin Sodium Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Heparin Sodium Market, By Product Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Unfractionated Heparin (UFH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Low Molecular Weight Heparin (LMWH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Heparin Sodium Market, By Source, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Porcine-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bovine-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Heparin Sodium Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Heparin Sodium Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Venous Thromboembolism (VTE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Atrial Fibrillation & Coronary Artery Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Kidney Dialysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Surgery & Critical Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Heparin Sodium Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dialysis Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Heparin Sodium Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Heparin Sodium Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aspen Pharmacare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LEO Pharma A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
